NHS England has announced that patients across England can now access general practice (GP) appointments in the evening and weekends, resulting in as many as nine million extra appointments per year.
News
Diabetes-related lower limb amputations jump nearly 20%
The number of diabetes related lower-limb amputations has leapt nearly 20% since 2013, according to a new report by Diabetes UK.
Novartis pulls EU filing for canakinumab
Novartis has pulled back its application to market canakinumab for the prevention of serious events such as stroke, myocardial infarction (MI) or death in patients who have had an MI in Europe.
Seven medicines leap closer to EU approval
The European Medicines Agency’s human medicines committee (CHMP) has put forward seven medicines for approval in the region.
Innovate UK grant for PredictImmune’s IBD drug response test
Innovate UK has awarded PredictImmune a £100,000 grant to apply its biomarker-based technology towards the prediction of drug response in IBD.
‘Significant’ Scotland health gap persists
A Scottish government Health and Social care report has shown that the gap in health outcomes between the most and least deprived areas is Scotland persist to be ‘significant’, despite welcome improvements in some areas.
UK men and women spending less of their lives in “good health”
A new report published by the Office of National Statistics has shown that for both sexes, the average amount of years lived in bad health has increased both in relative and in absolute terms, because life expectancy has risen more quickly than healthy life expectancy.
Sosei doses first patient with experimental neurodegenerative drug
Sosei has announced that the first healthy subject has been dosed with HTL0014242 – a novel small molecule being tested for its ability to slow neurodegeneration.
NHS performance ‘deeply troubling’, says NHS Confederation
A&E departments have suffered their worst November performance on record, with the number of patients seen within four hours dropping to 87.6% from 88.8% in November last year, according to performance data released by NHS England.
Shield expecting US decision on Feraccru in July
Shield Therapeutics has revealed that the US Food and Drug Administration will make a decision on its application to market Feraccru in the US by July 27 next year.
NICE rejects NHS funding for Tegsedi, Onpattro
The National Institute for Health and Care Excellence has issued draft guidelines rejecting NHS funding for two therapies that treat the rare inherited condition hereditary transthyretin-related amyliodsis (hATTR).
Experts call for national lung disease plan
Experts are calling for a national review and action plan to tackle lung disease to help ease annual winter pressures on the NHS.
AstraZeneca, AVEO Oncology form lung cancer collaboration
AVEO Oncology has announced the start of an immuno-oncology focused clinical collaboration with drug giant AstraZeneca (AZ).
Plaque psoriasis study claims Tremfya superior to Cosentyx
Janssen’s plaque psoriasis treatment Tremfya was found to be superior to Novartis’ Cosentyx in treating adults with moderate-to-severe cases of the condition, according to findings of a late-stage study.
Rural patients less likely to survive cancer, study finds
A new study has shown that people who live in rural areas are less likely to survive cancer than those who live in cities.
